Home > Boards > US Listed > Biotechs > Palisade Bio Inc (PALI)

PALI~~PIPELINEOur initial focus is improving patients’ quality of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ALERTS100%to10000%GAIN Member Profile
Member Level 
Followed By 981
Posts 76,276
Boards Moderated 17
Alias Born 03/10/09
160x600 placeholder
ALERTS100%to10000%GAIN Member Level  Tuesday, 05/04/21 07:48:01 AM
Re: None
Post # of 53 
PALI~~PIPELINE
Our initial focus is improving patients’ quality of life following major surgery by 1) accelerating postoperative return of gastrointestinal (GI) function to shorten their length of stay in the hospital and 2) prevention of post-surgical adhesions to reduce need for additional surgeries.

Additionally, we plan to pursue follow-on indications to address a myriad of health conditions and complications associated with chronic disruption of the intestinal mucosal barrier.

Our most advanced candidate, LB1143, is a Phase 3-ready oral protease inhibitor drug with the potential ability to protect intestinal integrity during and after surgery, representing a pipeline within a drug given the wide array of health complications that intestinal enzyme damage can cause.

https://www.palisadebio.com/pipeline/default.aspx



STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences